Clinician Link.AI ™️’s Post

🎥 Delve into the science of dosing with Dr. Peter Kaiser as he discusses the enhanced durability of Bayer | Ophthalmology 8 mg aflibercept. Learn how increasing the molar dose can extend the drug's half-life, offering tailored treatment intervals based on individual patient needs. Dr. Kaiser sheds light on the practical application of these findings, emphasizing the importance of a patient-centric approach in optimizing treatment outcomes. Explore the nuances of treat-and-extend paradigms with high-dose Eylea, and discover how personalized care is revolutionizing patient experiences in ophthalmology.  #COPHY2024 #Aflibercept8mg #OphthalmologyInnovation #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #glaucoma #Surgicalretina #uveitis #neuropathy COPHy Congress Simrat Sodhi

🎥 Join Dr. Peter Kaiser as he delves into the significant advancements in ophthalmic treatment with the introduction of Bayer | Ophthalmology 8 mg aflibercept. Discover how this higher dosage is making strides in patient care, allowing for extended treatment intervals and improved outcomes, especially for those with challenging cases. Dr. Kaiser shares his experiences and the promising results observed in two distinct patient groups, showcasing the drug's versatility and effectiveness. Tune in to gain valuable insights into this groundbreaking development in ophthalmology! #COPHY2024 #Aflibercept8mg #OphthalmologyInnovation #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #glaucoma #Surgicalretina #uveitis #neuropathy COPHy Congress

Functional outcome is one of the things we need to emphasize apart from anatomical reattachment in rrd surgery. This study highlighted what we can look for to achieve good functional vision post operative.

5 key takeaways from the National Institutes of Health-sponsored workshop's Working Definition of CVI, published by American Academy of Ophthalmology: Brain-based impairment Not fully explained by eye conditions Diverse visual challenges Links to other neurodevelopmental disorders Can occur across all ages Learn more: https://lnkd.in/dbWrJh9J #CVI #VisionResearch #HealthEquity

Unlock Mondays with an exciting publication! Are you interested in the factors influencing fluid resolution in neovascular age-related macular degeneration? Check out the publication 'Fluid Resolution Without Shortening Injection Interval During Subretinal Fluid-tolerating Treatment in Neovascular Age-related Macular Degeneration.' This study investigates the incidence of subretinal fluid resolution during treatment while maintaining injection intervals. What implications do these findings have for managing treatment strategies in AMD? Stay informed with the latest developments in ophthalmology. Discover it: https://lnkd.in/dwbFu6dB #Ophthalmology #Publication #NeovascularAMD #SubretinalFluid #TreatmentStrategies

An assessment of patients with Central Retinal Artery Occlusion published in the American Journal of Ophthalmology ! - Most present within 24 hours of symptoms and with elevated inflammatory makers - Visual recovery and reperfusion are possible, both with and without the presence of a cilioretinal artery - Total and inner retinal thickening was observed on OCT at presentation, with subsequent progressive retinal thinning stabilizing after 6 months. - This modern data set can serve as a comprehensive baseline analysis for future interventional trials Great work by Sandra Hoyek and thanks to the mentorship of Demetrios Vavvas on the project! https://lnkd.in/esB_-Ub3

🌟 Dive into the insights of Dr. Anat Loewenstein as she discusses the findings of the Barometer Study - research made possible with the support of Bayer | Ophthalmology - a global survey aimed at understanding patient needs and healthcare practitioner awareness in ophthalmology. Discover the surprising revelations about clinic accessibility, staff knowledge gaps, and patient communication. Dr. Loewenstein's discussion sheds light on crucial areas needing attention in eye care, sparking conversations on how to enhance patient experience and staff education. Join us for this eye-opening session! #COPHY2024 #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #glaucoma #Surgicalretina #uveitis #neuropathy COPHy Congress Simrat Sodhi Anat Loewenstein Vision Academy

#Publicationalert Glad to share our recent publication in the British Journal of Ophthalmology! We have shared interesting results on the adjuvant role of topical cyclosporine 1% in acute Stevens-Johnson syndrome. Check out the latest insights in ophthalmology research! #Ophthalmology #ResearchPublication PS- Feels good to be back in research!

Join Arthur B. Cummings, MBChB, FCS(SA), MMed(Ophth), FRCSEd, FWCRS, and Aylin Kılıç, MD, as they dive into key findings from the 2024 AECOS Europe Symposium. This insightful discussion covers patient happiness with residual refractive errors, neuroadaptation to residual astigmatism, and the promising future of allograft inlays for presbyopia and keratoconus. Discover the latest advancements and how they are shaping the future of ophthalmology. 🔗 Watch here: https://bit.ly/4biJmDj #Ophthalmology #AllograftInlays #Presbyopia #Keratoconus #AECOSEurope2024 #EyeCareInnovation